Clinical Trial Update: Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gefitinib in combination with radiotherapy for elderly patients with esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Gefitinib (Iressa) (gefitinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN